Abstract
The need for an effective vaccine against human immunodeficiency virus type 1 (HIV-1) is one of the priorities in research worldwide. So far, none of the experimental vaccines tested clinically in humans showed significant protection. Although CD8 + cytotoxic T lymphocyte anti-HIV-1 are those that effectively destroy virus-infected cells, its activity is primarily dependent on the presenc…